Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637)
09/2011
09/15/2011WO2011112089A2 Mutated rep encoding sequences for use in aav production
09/15/2011WO2011110073A1 Isolation and purification method of cell culture mixture
09/15/2011WO2011057248A3 Methods of propagating monkey adenoviral vectors
09/15/2011US20110223199 METHOD FOR PRODUCTION OF pH STABLE ENVELOPED VIRUSES
09/15/2011US20110223135 SIMIAN ADENOVIRUSES SAdV-43, -45, -46, -47, -48, -49, AND -50 AND USES THEREOF
09/14/2011EP2365082A1 BVDV virus-like particles
09/14/2011CN102181480A A method of detecting and/or identifying adeno-associated virus (AAV) sequences and isolating novel sequences identified thereby
09/14/2011CN102181461A Method for expressing target polypeptide on filobactivirus at high density and application thereof
09/14/2011CN102181408A Preparation method and application of Saint Louis encephalitis virus-like particles
09/14/2011CN102181407A Recombinant adenovirus and dendritic cell modified by recombinant adenovirus and application of recombinant adenovirus and dendritic cell
09/14/2011CN102181406A Recombinant adenovirus, dendritic cell (DC) modified by recombinant adenovirus and application of recombinant adenovirus and DC
09/14/2011CN102181405A Recombinant virus and method for producing L-asparaginase II by using virus
09/14/2011CN102181404A Recombinant adenovirus expressing E0, E2 gene of classical swine fever virus
09/14/2011CN102181403A Research on technology for artificially modifying extended-spectrum bacteriophage
09/14/2011CN102181399A Mouse liver tumor cell line for highly expressing CD133 and preparation method thereof
09/14/2011CN102180951A Cholesterol modified anti-human immunodeficiency virus (HIV) polypeptide medicament and application thereof
09/14/2011CN102178948A Genetic engineering drug for treating and/or preventing cervical cancer
09/14/2011CN102178947A Live vector vaccine for expressing peste des petits ruminants virus (PPRV) H gene and preparation method thereof
09/14/2011CN102178946A Application of baby hamster kidney(BHK)-21 cell serum-free suspension culture technology in foot-and-mouth disease vaccine production
09/14/2011CN101186637B Method for inhibiting influenza virus infection and medicament thereof
09/13/2011US8017590 Method of inducing and/or enhancing an immune response to tumor antigens
09/13/2011US8017317 Equine herpes viruses (EHV) with immunomodulatory capacity; respiratory and neurological diseases
09/13/2011US8017154 Polyamino acid for use as adjuvant
09/13/2011US8017127 Influenza immunogen and vaccine
09/13/2011CA2329060C Aav5 vector and uses thereof
09/13/2011CA2220964C Alphavirus rna replicon systems
09/09/2011WO2011107534A1 Recombinant attenuated parvovirus
09/09/2011WO2011107439A1 A method for measuring viral infectivity
09/09/2011CA2790653A1 Recombinant attenuated parvovirus
09/08/2011US20110219464 Lung disease targets and uses thereof
09/08/2011US20110217772 Animal protein free media for cultivation of cells
09/08/2011US20110217757 Modified vaccinia ankara virus variant and cultivation method
09/08/2011US20110217756 Newly isolated bacteriophage specific to klebsiella pneumoniae
09/08/2011US20110217749 Method for the cultivation of primary cells and for the amplification of viruses under serum free conditions
09/08/2011US20110217693 Generation of Replication Competent Viruses for Therapeutic Use
09/08/2011US20110217332 Chimpanzee Adenovirus Vaccine Carriers
09/08/2011US20110217330 Novel method
09/08/2011US20110217267 Gene therapy vectors and cytosine deaminases
09/08/2011US20110217266 Genomic sequence of avian paramyxovirus type 2 and uses thereof
09/07/2011EP2363493A1 Novel insertion sites in pox vectors
09/07/2011EP2363464A1 DNA modular cloning vector plasmids and methods for their use
09/07/2011EP2363462A1 Novel baculoviral vector
09/07/2011EP2362901A1 Improved methods for isolating enveloped virus-based vlps free of infectious agents
09/07/2011CN1840204B Lentiviral vectors for the preparation of immunotherapeutical compositions
09/07/2011CN102177233A Virus-like particles comprising composite capsid amino acid sequences for enhanced cross reactivity
09/07/2011CN102174508A Method for screening non-essential regions for replication of goat pox virus and universal transfer vectors for same
09/07/2011CN102174482A Method for separating and purifying phycophage from blue algae outbreak water body
09/07/2011CN102174481A Cotton leafworm genetically engineered virus I and construction method thereof
09/07/2011CN102174480A Prodenia litura genetically engineered virus NO.2 and construction method thereof
09/07/2011CN102174479A Oncolytic virus for targeted treatment of human tumors and application thereof
09/07/2011CN102174478A Photosensitizer binding protein/polypeptide and application thereof to photodynamic gene therapy
09/07/2011CN102174477A Hepatitis A virus strain SH and diploid cell adaptation method thereof
09/07/2011CN102174476A Inactivated vaccine for preventing duck virus hepatitis and preparation method thereof
09/07/2011CN102174473A K562-PM-RFP cell strain
09/07/2011CN102174468A Method and application for inducing human umbilical cord mesenchyme stem cells to be differentiated into testicular interstitial cells
09/07/2011CN102174466A Porcine somatic cell mutagensis method
09/07/2011CN102174444A Method for proliferating H9 subtype avian influenza virus and pasteurella by chick embryos
09/06/2011US8012749 Methods for the production of hemagglutinating virus of Japan and adenovirus using cultured cells
09/06/2011US8012748 Peripheral nervous system specific sodium channel nucleic acids
09/06/2011US8012738 Purification of vaccinia virus- and recombinant vaccinia virus-based vaccines
09/06/2011US8012737 Methods of producing influenza vaccine compositions
09/06/2011US8012736 Multi plasmid system for the production of influenza virus
09/06/2011US8012735 Infectious cDNA clone of the modified live virus vaccine strain of Equine arteritis virus
09/06/2011CA2427578C A recombinant newcastle disease virus nucleoprotein mutant as a marker vaccine
09/01/2011WO2011106743A1 Recombinant cdv compositions and uses thereof
09/01/2011WO2011070440A3 Oncolytic rhabdovirus
09/01/2011US20110212986 Anti-flavivirus therapeutic
09/01/2011US20110212859 Radio frequency identifiers for use in biological science
09/01/2011US20110212493 Perfusion bioreactors, cell culture systems, and methods for production of cells and cell-derived products
09/01/2011US20110212488 Immortalized avian cell lines and use thereof
09/01/2011US20110212434 Novel hiv-based recombinant viral clones and use thereof in analytical methods
09/01/2011US20110212162 Lymphatic zip codes in tumors and pre-malignant lesions
09/01/2011US20110212130 Live, attenuated respiratory syncytial virus
09/01/2011US20110212117 Influenza hemagglutinin and neuraminidase variants
09/01/2011US20110212085 Lung cancer disease targets and uses thereof
09/01/2011US20110212056 Combination therapy for the treatment of liver diseases
09/01/2011CA2791787A1 Recombinant cdv compositions and uses thereof
08/2011
08/31/2011EP2361975A1 Method for influenza virus purification
08/31/2011EP2361974A1 Use of proteins and peptides encoded by the genome of a new coronavirus strain associated with SARS
08/31/2011EP2361304A2 Novel method
08/31/2011CN1833024B Nucleic acid construct containing hepatitis c virus (hcv) of genocype 2a genome-origin nucleic acid and cell having the nucleic acid construct transferred thereinto
08/31/2011CN102171334A Method for producing purified influenza virus antigen
08/31/2011CN102168075A Recombinant adenovirus carrying rat retinoic acid receptor (RAR) gamma gene and construction method thereof
08/31/2011CN102168074A Recombinant adenovirus and application thereof
08/31/2011CN102168073A Method for improving proliferation capability of mycoplasma gallisepticum in vaccine production
08/31/2011CN102168070A Human laryngeal epithelium cancer cell as well as preparation method and application thereof
08/31/2011CN102166228A A method of treating a malignancy in a subject via direct picornaviral-mediated oncolysis
08/31/2011CN102165901A Method for preventing and treating Pseudomonas solanacearum
08/30/2011US8008460 Polynucleotide fragments of an infectious human endogenous retrovirus
08/30/2011US8008000 Viral variants detection and application
08/30/2011US8007817 Compositions and methods for treating microbial infections
08/30/2011US8007792 Antibodies directed against hepatitis C virus E1E2 complex, compositions of HCV particles, and pharmaceutical compositions
08/30/2011CA2491872C Virulent phages to control listeria monocytogenes in foodstuffs and in food processing plants
08/30/2011CA2405458C Herpes viruses for immune modulation
08/25/2011WO2011103185A1 Human group p immunodeficiency virus and uses thereof
08/25/2011WO2011103137A1 Cell-based methods and reagents
08/25/2011WO2011080505A3 Method of growing phage for commercial use
08/25/2011US20110209228 Method of treatment using antimicrobial composition
08/25/2011US20110207223 Methods of generating alphavirus particles
08/25/2011US20110207202 Method for the production of adenoviral vectors
1 ... 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 ... 267